ES2103722T3 - Utilizacion de analogos de la prostaciclina contra las metastasis. - Google Patents

Utilizacion de analogos de la prostaciclina contra las metastasis.

Info

Publication number
ES2103722T3
ES2103722T3 ES90250257T ES90250257T ES2103722T3 ES 2103722 T3 ES2103722 T3 ES 2103722T3 ES 90250257 T ES90250257 T ES 90250257T ES 90250257 T ES90250257 T ES 90250257T ES 2103722 T3 ES2103722 T3 ES 2103722T3
Authority
ES
Spain
Prior art keywords
prostacicline
analogs
against metastasis
metastasis
eptaloprost
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90250257T
Other languages
English (en)
Inventor
Martin Schneider
Ekkehard Schillinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2103722T3 publication Critical patent/ES2103722T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicon Polymers (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

LA INVENCION ES RELATIVA A UN AGENTE QUE ACTUA CONTRA LA METASTASIS QUE SE COMPONE DE EPTALOPROST, CICAPROST, O COMBINACIONES DE ANTAGONISTAS TXA2 Y DERIVADOS DE PROSTACICLINA.
ES90250257T 1989-10-05 1990-10-05 Utilizacion de analogos de la prostaciclina contra las metastasis. Expired - Lifetime ES2103722T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3933523A DE3933523A1 (de) 1989-10-05 1989-10-05 Antimetastatisch wirkende mittel

Publications (1)

Publication Number Publication Date
ES2103722T3 true ES2103722T3 (es) 1997-10-01

Family

ID=6391016

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90250257T Expired - Lifetime ES2103722T3 (es) 1989-10-05 1990-10-05 Utilizacion de analogos de la prostaciclina contra las metastasis.

Country Status (20)

Country Link
EP (1) EP0421562B1 (es)
JP (1) JP3241373B2 (es)
AT (1) ATE152624T1 (es)
AU (1) AU645038B2 (es)
CA (1) CA2067395C (es)
DE (2) DE3933523A1 (es)
DK (1) DK0421562T3 (es)
ES (1) ES2103722T3 (es)
FI (1) FI921474A0 (es)
GR (1) GR3024183T3 (es)
HU (2) HUT61197A (es)
IE (1) IE903569A1 (es)
IL (1) IL95902A (es)
NO (1) NO921317D0 (es)
NZ (2) NZ235585A (es)
PT (1) PT95517B (es)
RU (1) RU2112514C1 (es)
UA (1) UA27781C2 (es)
WO (1) WO1991004739A1 (es)
ZA (1) ZA907996B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3230246B2 (ja) * 1991-04-11 2001-11-19 東レ株式会社 悪性腫瘍転移抑制剤
US5496850A (en) * 1991-04-11 1996-03-05 Toray Industries, Inc. Antimetastasis agent of malignant tumors
RU2308097C2 (ru) * 2005-09-27 2007-10-10 Валерий Хажмуратович ЖИЛОВ Способ снижения метастазирования карциномы легкого льюис
RU2385153C1 (ru) * 2008-12-01 2010-03-27 Михаил Владимирович Кутушов Применение жидких кристаллов в качестве лекарственных препаратов

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226550A1 (de) * 1982-07-13 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3306123A1 (de) * 1983-02-18 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3835162A1 (de) * 1988-10-13 1990-04-19 Schering Ag (1s,2s,3r,5r)-2-((3s)-2-halogen-3-hydroxy-1-alken(inyl))-3-trialkylsilyloxy-7,7-(2,2-dimethyl-trimethylendioxy)-bicyclo-(3.3.0)-octan-verbindungen und verfahren zu deren herstellung

Also Published As

Publication number Publication date
UA27781C2 (uk) 2000-10-16
DE3933523A1 (de) 1991-04-11
DK0421562T3 (da) 1997-10-13
JP3241373B2 (ja) 2001-12-25
EP0421562A3 (en) 1992-09-02
RU2112514C1 (ru) 1998-06-10
HU9201134D0 (en) 1992-07-28
HU210934B (en) 1995-09-28
NO921317L (no) 1992-04-03
IE903569A1 (en) 1991-04-10
CA2067395C (en) 2002-04-23
PT95517A (pt) 1991-09-30
EP0421562B1 (en) 1997-05-07
AU645038B2 (en) 1994-01-06
ZA907996B (en) 1991-07-31
CA2067395A1 (en) 1991-04-06
HUT61197A (en) 1992-12-28
EP0421562A2 (en) 1991-04-10
FI921474A7 (fi) 1992-04-03
IL95902A (en) 1996-01-31
FI921474A0 (fi) 1992-04-03
IL95902A0 (en) 1991-07-18
NO921317D0 (no) 1992-04-03
GR3024183T3 (en) 1997-10-31
AU6501790A (en) 1991-04-28
JPH05502860A (ja) 1993-05-20
WO1991004739A1 (en) 1991-04-18
DE69030635D1 (de) 1997-06-12
NZ235585A (en) 1997-03-24
ATE152624T1 (de) 1997-05-15
NZ245941A (en) 1997-02-24
PT95517B (pt) 1997-11-28

Similar Documents

Publication Publication Date Title
AR002932A1 (es) Solucion acuosa de interferon
ES2145477T3 (es) Compuestos funcionales de 1,3-dicetoamida etilenicamente insaturados, sus polimeros y formulaciones de latex que los contienen.
AR021151A1 (es) Agentes desmoldantes
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
HN1997000161A (es) Prevencion de la perdida de restauracion de la masa osea por determinados agonistas de prostaglandinas.
ES2145428T3 (es) Empleo de productos de alcoxilacion de grasas epoxidadas como desespumantes.
ES2172069T3 (es) Derivado tetrapeptidico.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
AR011734A1 (es) Analogos del peptido lh-rh, y composiciones farmaceuticas que los contienen
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
ES2115656T3 (es) Analogos de tocoferol cardioprotectores.
ES2053988T3 (es) Un metodo para la produccion de una composicion eficaz para traqueobroncodilatacion.
ES2089424T3 (es) Tensioactivos glicolipidicos y composiciones que los contienen.
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2103722T3 (es) Utilizacion de analogos de la prostaciclina contra las metastasis.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.
EA200100185A1 (ru) Композиция для освежения ноздрей и пазушных полостей
ES2069921T3 (es) Antagonistas del nmda.
ES2117362T3 (es) Composicion cosmetica o farmaceutica que contiene un carbamato de alquilo como agente hidratante.
ES2144145T3 (es) Produccion de hidrofluoralcanos.
ES2091420T3 (es) Nuevos derivados esteroides del pregna-4,9(11),17(20)-trien-3-ona, su preparacion, su aplicacion en la preparacion de compuestos esteroides del tipo pregna-4,9(11),16-trien-3,20-diona y nuevos compuestos intermedios.
ES2121463T3 (es) Uso de procisteina como agente blanqueante de la piel.
IT1253898B (it) Ammortizzatore, in particolare utilizzabile in macchine lavabiancheria
ES2081916T3 (es) Delta-lactonas naturales y procedimiento para su fabricacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 421562

Country of ref document: ES